Sanofi (SNY) Tops Q4 EPS by 74c

Sanofi (NASDAQ: SNY) reported Q4 EPS of EUR1.66, EUR0.74 better than the analyst estimate of EUR0.92. Revenue for the quarter came in at EUR10.92 billion versus the consensus estimate of EUR12.65 billion.

For earnings history and earnings-related data on Sanofi (SNY) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Freeport Q3 2026 copper output meets targets; gold sales deferred
• RBC cuts Northrop Grumman rating on slower growth, cautious defense outlook